Anaconda Biomed, Vivacell, Devicare and Apta Targets are the Spanish biotechs that have secured investor backing in May with the aim of bringing their products to market.
M&A advisors with expertise in the technology sector
biotechnology investment
Latest Sectoral Reports |
Last Entries
Investors lose their fear of investing in biotechnology
In the last few months, three financing rounds totalling almost €70M have taken place in Spain, those of Sanifit, Minoryx and Aelix Therapeutics, and one IPO, that of Oryzon. These figures confirm the boom in the sector, not only for domestic investors but also for foreign investors. This January we have already seen investments such as Inveready's investment in Oncostellae and that of Aelix Therapeutics.
France's Synerlab buys Alcalá Pharma
If a week ago we told you that Spanish biotechs were going public on the MAB, this week it is the turn of crowdfunding and acquisitions in the biotech sector.